الفهرس 
IntroductionOnly 14 pages are availabe for public view
Abstract
Cardiovascular disease is the leading cause of death and disability in the United States and most of societies. During the past 3 decades efficacious strategies have been developed for primary and secondary prevention of these diseases. These trends are potentially reversible with the optimal assessment and management of cardiovascular disease risk factors, of which dyslipidemia is prominent.
A study was conducted in the period between May 1977 and October 1999. The study population was over 6666 subjects in 26 govemorates in Egypt representing different geographical regions of the country. Prevalence of CHD was 6% in males, 4.7% in females and the over all prevalence was 5.2%.
The National Cholesterol Education Program (NCEP) developed guidelines for treatment and released the third report of the expert panel on the detection, evaluation, and treatment of high blood cholesterol in adults in April of2001 Adult Treatment Panel [ATP] III, And proposed modifications based on new clinical trial evidence in July 2004.
Family physicians have the potential to considerably reduce the burden of cardiovascular disease through the optimal assessment and management of dyslipidemia. This study was aiming at improve family physicians’ knowledge, beliefs and practice towards dyslipidemia starting with assessment of their self-reported practice patterns regarding management of dyslipidemia.
Barriers to assessment of coronary heart disease risk in their patients showed that adherence of the patients had reported by the highest percentage of physicians (80.7%), followed by the cost of investigations (68.4%), knowledge of the physician (36.8%), system factors (36.8%), time of physician (21.9%) and lowest percentage (17.5%) was toward doctor patient relationship.
Barriers to treatment of dyslipidemia showed that adherence of the patients had reported by the highest percentage of physicians (84.2%), followed by the cost of drugs (73.7%), knowledge of the physician (44.7%), health habits (43.9%), time of physician (14%), system factors (7.9%), and lowest percentage (7%) was toward doctor patient relationship.
There was statistically significant relation between gender of physicians, reading of NCEP ATP III guideline and quality of reading and physicians’ score on dyslipidemia screening and assessment practice and on dyslipidemia management practice.
This study demonstrates that not all recommendations of the NCEP ATP III guidelines have been adopted in clinical practice by most studied family physicians. It also demonstrates the large degree of practice variation regarding dyslipidemia assessment and management.